These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 32696934

  • 1. Clinical and epidemiological characteristics of M. kansasii pulmonary infections from Rio de Janeiro, Brazil, between 2006 and 2016.
    Goldenberg T, Gayoso R, Mogami R, Lourenço MC, Ramos JP, Carvalho LD, Dalcolmo MP, Mello FCQ.
    J Bras Pneumol; 2020; 46(6):e20190345. PubMed ID: 32696934
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mycobacterium kansasii.
    Johnston JC, Chiang L, Elwood K.
    Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28185617
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients: five year follow-up of patients receiving standardised treatment.
    Jenkins PA, Campbell IA, Research Committee of The British Thoracic Society.
    Respir Med; 2003 Apr; 97(4):439-44. PubMed ID: 12693807
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Temporal interferon-gamma release response to Mycobacterium kansasii infection in an anorexia nervosa patient.
    Cosson MA, Bertrand JB, Martin C, Veziris N, Picard C, Goulvestre C, Coignard S, Benoit JP, Silvera S, Moro MR, Poyart C, Morand PC.
    J Med Microbiol; 2012 Nov; 61(Pt 11):1617-1620. PubMed ID: 22859583
    [Abstract] [Full Text] [Related]

  • 13. First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol.
    Research Committee of the British Thoracic Society.
    Thorax; 2001 Mar; 56(3):167-72. PubMed ID: 11182006
    [Abstract] [Full Text] [Related]

  • 14. Mycobacterium kansasii pulmonary diseases in Korea.
    Yim JJ, Park YK, Lew WJ, Bai GH, Han SK, Shim YS.
    J Korean Med Sci; 2005 Dec; 20(6):957-60. PubMed ID: 16361804
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical characteristics and treatment outcomes of Mycobacterium kansasii lung disease in Korea.
    Park HK, Koh WJ, Shim TS, Kwon OJ.
    Yonsei Med J; 2010 Jul; 51(4):552-6. PubMed ID: 20499421
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Swelling of right knee in an immunologically compromised patient].
    Cajigas-Pezo D, Lorenzo-Hernandez A, Vives-Rivero GR, Rentero-Martínez Z.
    Enferm Infecc Microbiol Clin; 2012 Oct; 30(8):481-2. PubMed ID: 22521279
    [No Abstract] [Full Text] [Related]

  • 19. [Disseminated disease by Mycobacterium kansasii resistant to isoniazid and rifampin in patients] with AIDS].
    Ibarrola M, Baraia-Etxaburu J, Sánchez R, Teira R, Unzaga J, Miguel Santamaría J.
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(2):80-2. PubMed ID: 11333577
    [No Abstract] [Full Text] [Related]

  • 20. [Distribution and drug resistance of nontuberculous Mycobacteria in Beijing].
    Zhang J, Su JR, Ding BC, Liu JW, Yi JL, Yang XY, Wang NH, Wang SM.
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Mar 12; 40(3):210-214. PubMed ID: 28297817
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.